Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy

AIDS

Volumn 10, Issue 3, 1996, Pages 263-268

  Heald, Alison E ^a   Cox, Gary M ^a   Schell, Wiley A ^a   Bartlett, John A ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIDS; Candida; Drug resistance; Fluconazole; HIV; Susceptibility testing

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; FUNGUS GROWTH; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; MYCOSIS; ORAL DRUG ADMINISTRATION; OROPHARYNX; PRIORITY JOURNAL; RECURRENCE RISK; SYMPTOM; YEAST;

EID: 0029935052     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199603000-00004     Document Type: Article

References (25)

1. Greenspan JS, Greenspan D, Winkler JR: Oral complications of HIV infection. In The Medical Management of AIDS 3rd Edn. Edited by Sande MA, Volberding PA. Philadelphia: WH Saunders Company; 1992:161-175.
2. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994, 330:263-272.
3. Powderly WG, Finkelstein DM, Feinberg J, et al.: A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995, 332:700-705.
4. Boken DJ, Swindells S, Rinaldi MG: Fluconazole-resistant Candida albicans. Clin Infect Dis 1993, 17:1018-1021.
5. Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR: Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993, 37:2449-2453.
6. Chavanel P, Lopez J, Grappin M, et al.: Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994, 8:945-950.
7. Sandven P, Bjorneklett A, Maeland A, and the Norwegian Yeast Study Croup: Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrob Agents Chemother 1993, 37:2443-2448.
8. Troillet N, Durussel C, Bille J, Glauser MP, Chave JP: Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993, 12:911-915.
9. Vuffray A, Durussel D, Boerlin P, et al.: Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients [letter]. AIDS 1994, 8:708-709.
10. Baily GG, Perry FM, Denning DW, Mandal BK: Fluconazole-resistant candidiasis in an HIV cohort. AIDS 1994, 8:787-792.
11. White A, Goetz MB: Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994, 19:687-692.
12. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M: Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidiasis and human immunodeficiency virus infection. J Clin Microbiol 1994, 32:2092-2098.
13. Rex JH, Rinaldi MG, Pfaller MA: Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995, 39:1-8.
14. Johnson EM, Luker J, Scully C, Warnock DW: Azole-resistant Candida species among HIV-positive patients given long-term fluconazole for oral candidiasis. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 1993 [abstract 741].
15. Ng TTC, Denning DW: Fluconazole resistance in Candida in patients with AIDS - a therapeutic approach. J Infect 1993, 26:117-125.
16. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B: Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993, 31:2933-2937.
17. Millon L, Manteaux A, Reboux G, et al.: Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994, 32:1115-1118.
18. Redding S, Smith J, Farinacci G, et al.: Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994, 18:240-242.
19. Sangeorzan JA, Bradley SF, He X, et al.: Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994, 97: 339-346.
20. Pfaller MA, Rhine-Chalberg J, Redding SW, et al.: Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994, 32:59-64.
21. Perfect JR, Savani DV, Durack DT: Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob Agents Chemother 1986, 29:579-583.
22. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Proposed Standard M27-P. Villanova: National Committee for Clinical Laboratory Standards; 1992.
23. He X, Tiballi RN, Zarins LT, Bradley SF, Sangeorzan JA, Kauffman CA: Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994, 38:2495-2497.
24. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG: In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994, 38:1530-1533.
25. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R: Increase in Candida krusei infected among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991, 325:1274-1277.